Market Cap
$2.7B
ATAI
AtaiBeckley Inc.
—
Market cap$2.7B
ConsensusSell
12-mo target$8.12 (+10.4%)
▼ Bearish
Analyst conviction 3/10
Insider Selling Cluster (3 insiders)High Impact Filing (9/10)42 New Institutional Positions8 Institutional Exits
Snapshot
The big-picture read on ATAI right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Hold (33%)
Inst. Holders
50 funds
Inst. Value
$532.1M
Inst. Activity
42 buys / 8 sells
Social Sentiment
65° Warm
SEC Reports
11
Press Releases
6
Price chart 30d +0.1%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 14, 2026 listing_status
Sep 11, 2026 SEC Delisted: ATAI — removed from the Nasdaq symbol directory
AtaiBeckley Inc. - Common Stock
Nasdaq filed a Form 25-NSE to remove AtaiBeckley Inc. (ATAI) common stock from listing and registration under Section 12
25-NSE — Impact 9/10
Sep 11, 2026 Insider
Johnson Anne Nagengast disposed of 140,045 shares
Chief Accounting Officer
Sep 11, 2026 Insider
Fischer Laurent disposed of 121,968 shares
Director
Sep 11, 2026 Insider
Aug 10, 2026 SEC Kochendoerfer Gerd disposed of 1,400,000 shares
Chief Operating Officer
AtaiBeckley shareholders are asked to vote on the acquisition by Eli Lilly for $6.75 per share in cash plus one CVR per
DEFM14A — Impact 7/10
12 institutional investors accumulated $7.0M in ATAI during Q2 2026, with zero sellers. Bank of New York Mellon ($4.7M)
INST-CLUSTER — Impact 6/10
Jun 30, 2026 Inst.
BlackRock, Inc. — DOUBLED
25,574,573 shares ($134.8M)
Analyst ratings buy % -65.3%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
33% rate it Buy or better · 21 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 12, 2026 | Deutsche Bank | DOWNGRADE | Hold | 58% |
| Jul 20, 2026 | HC Wainwright & Co. | DOWNGRADE | Neutral | 43% |
| Jul 17, 2026 | Guggenheim | DOWNGRADE | Neutral | 52% |
| Jul 17, 2026 | Jones Trading | DOWNGRADE | Hold | 51% |
| Jul 17, 2026 | Jefferies | DOWNGRADE | Hold | 53% |
| Jul 16, 2026 | Maxim Group | DOWNGRADE | Hold | 43% |
| Jul 16, 2026 | Canaccord Genuity | DOWNGRADE | Hold | 47% |
| Jul 16, 2026 | Needham | DOWNGRADE | Hold | 50% |
| Jul 7, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
| Jul 6, 2026 | Jefferies | MAINTAIN | Buy | 53% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 5 | 14 | 0 | 0 | 33% | |
| Aug 1, 2026 | 3 | 6 | 12 | 0 | 0 | 43% | |
| Jul 1, 2026 | 6 | 14 | 1 | 0 | 0 | 95% | |
| Jun 1, 2026 | 5 | 14 | 1 | 0 | 0 | 95% | |
| May 1, 2026 | 5 | 14 | 1 | 0 | 0 | 95% | |
| Apr 1, 2026 | 5 | 14 | 1 | 0 | 0 | 95% | |
| Mar 1, 2026 | 5 | 13 | 1 | 0 | 0 | 95% |
Price targets
Where 6 covering analysts think ATAI trades over the next 12 months.
$8.12 +10.4% upside Buy
Current$7.35 Low$7.45 Median$7.75 High$9.25 6 analysts
$7.45$9.25
Analyst rating Hold· 2.8/5 as of Oct 2, 2026
Social media sentiment mood -33.3%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
65°
Warm
BearishNeutralBullish
Recent posts
Bought 102 ATAI LEAPS for 2027/2028. OCC just moved expiration to next week. Am I screwed?
▲ 1 · 💬 5· ⚡ 0.5
Helus Pharma (HELP): a broad-label psychedelic, one pivotal readout from a massive re-rating
▲ 1 · 💬 5· ⚡ 0.5
$ATAI investors are furious... Should $ENHA investors pay attention?
▲ 1 · 💬 0· ⚡ 0.5
Big Pharma wants psychedelics?
▲ 1 · 💬 6· ⚡ 0.5
16 JULY 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?
▲ 1 · 💬 1· ⚡ 0.5
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
11 SEC filing reports analyzed · 3 bullish, 1 bearish, 1 mixed, 6 neutral · avg impact 4.7/10.Plus 6 press releases.
BEARISH25-NSE9/10
Nasdaq filed a Form 25-NSE to remove AtaiBeckley Inc. (ATAI) common stock from listing and registrat
Sep 11, 2026
BULLISHDEFM14A7/10
AtaiBeckley shareholders are asked to vote on the acquisition by Eli Lilly for $6.75 per share in ca
Aug 10, 2026
BULLISHINST-CLUSTER6/10
12 institutional investors accumulated $7.0M in ATAI during Q2 2026, with zero sellers. Bank of New
Aug 9, 2026
BULLISHDEFA14A, 8-K7/10
Eli Lilly (LLY) has agreed to acquire AtaiBeckley (ATAI) for $6.75 per share in cash plus up to $2.5
Jul 16, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 14, 2026
listing_status
Delisted: ATAI — removed from the Nasdaq symbol directory
AtaiBeckley Inc. - Common Stock
Sep 14, 2026
trading_halt
Halt Resumed: ATAI — trading resumed after D (Security Deletion)
Halted 2026-09-10T23:50:00.000Z | Resumed 2026-09-14T04:00:01.000Z
Sep 10, 2026
trading_halt
Trading Halt: ATAI — T12 (Additional Information Requested)
AtaiBeckley Inc. Common Stock | Market: NASDAQ | Code: T12 — Additional Information Requested
Sep 10, 2026
trading_halt
Trading Halt: ATAI — D (Security Deletion)
AtaiBeckley Inc. Common Stock | Market: NASDAQ | Code: D — Security Deletion
Sep 8, 2026
short_volume
Short Volume: ATAI — 57.0% short (9.5M / 16.6M)
Short: 9,456,108 | Exempt: 75 | TRF Vol: 16,583,829 | Short Ratio: 57.0% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.12 | $-0.16–$-0.10 | 57.3% | -9.2% | 0↑ 2↓ | $0.0B | 5 |
| Next Q | $-0.13 | $-0.18–$-0.10 | 92.4% | -10.3% | 0↑ 2↓ | $0.0B | 5 |
| Current FY | $-0.42 | $-0.52–$-0.37 | 85.4% | -7.7% | 1↑ 2↓ | $0.0B | 5 |
| Next FY | $-0.48 | $-0.75–$-0.38 | -13.1% | -7.0% | 2↑ 1↓ | $0.0B | 7 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.120 | — |
| 7d ago | $-0.120 | +0.000 |
| 30d ago | $-0.110 | -0.010 |
| 60d ago | $-0.122 | +0.003 |
| 90d ago | $-0.122 | +0.003 |
Institutional ownership
Which big funds own ATAI (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $532.1M total value (101,065,411 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, STATE. Net buying activity: 42 institutions added/increased vs 8 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 25,574,573 | $134.8M | 25.3% | DOUBLED +274.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 11,747,249 | $61.9M | 11.6% | — |
| STATE STREET CORP | 8,287,054 | $43.7M | 8.2% | DOUBLED +624.2% |
| GEODE CAPITAL MANAGEMENT, LLC | 6,933,309 | $36.5M | 6.9% | DOUBLED +176.2% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,642,758 | $29.7M | 5.6% | — |
| UBS Group AG | 4,424,701 | $23.3M | 4.4% | TRIM -40.4% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,106,450 | $21.6M | 4.1% | NEW |
| MORGAN STANLEY | 3,843,253 | $20.3M | 3.8% | — |
| Candriam S.C.A. | 3,039,399 | $16.0M | 3.0% | — |
| NORTHERN TRUST CORP | 2,589,167 | $13.6M | 2.6% | DOUBLED +381.2% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | DOUBLED | 6,835,300 | 25,574,573 | +274.2% | $134.8M |
| STATE STREET CORP | DOUBLED | 1,144,355 | 8,287,054 | +624.2% | $43.7M |
| GEODE CAPITAL MANAGEMENT, LLC | DOUBLED | 2,509,974 | 6,933,309 | +176.2% | $36.5M |
| UBS Group AG | TRIM | 7,426,867 | 4,424,701 | -40.4% | $23.3M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | NEW | — | 4,106,450 | — | $21.6M |
| NORTHERN TRUST CORP | DOUBLED | 538,050 | 2,589,167 | +381.2% | $13.6M |
| CITADEL ADVISORS LLC | DOUBLED | 171,388 | 2,114,908 | +1134.0% | $11.1M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 1,181,583 | 1,965,683 | +66.4% | $10.4M |
| MILLENNIUM MANAGEMENT LLC | TRIM | 4,364,096 | 1,770,526 | -59.4% | $9.3M |
| VANGUARD FIDUCIARY TRUST CO | ADD | 1,256,731 | 1,576,296 | +25.4% | $8.3M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
13 insiders, 50 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Johnson Anne Nagengast | Chief Accounting Officer | D | 140,045 | — | — |
| Sep 11, 2026 | Fischer Laurent | Director | D | 121,968 | — | — |
| Sep 11, 2026 | Kochendoerfer Gerd | Chief Operating Officer | D | 1,400,000 | — | — |
| Sep 11, 2026 | Rao Srinivas | See remarks | D | 600,000 | — | — |
| Sep 11, 2026 | Angermayer Christian | Director | D | 1,799,302 | — | — |
| Sep 11, 2026 | Kochendoerfer Gerd | Chief Operating Officer | D | 675,000 | — | — |
| Sep 11, 2026 | Kochendoerfer Gerd | Chief Operating Officer | D | 150,000 | — | — |
| Sep 11, 2026 | Smiley Andrea Heslin | Director | D | 4,666 | — | — |
| Sep 11, 2026 | Braunstein Scott | Director | D | 206,000 | — | — |
| Sep 11, 2026 | Rao Srinivas | See remarks | D | 650,795 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for ATAI.
Shares short
19,201,689
Settlement Aug 31, 2026
Change vs prior
+13.9%
Semi-monthly cycle
Days to cover
2.8
At avg daily volume
Of shares outstanding
≈5.2%
Estimate — not % of float
| Halted | Code | Reason | Status |
|---|---|---|---|
| Sep 10, 2026 | T12 | Info Requested | Not resumed |
| Sep 10, 2026 | D | Deletion | Resumed |
All ATAI filing & press-release reports (17)
- 25-NSE reportSep 11, 2026
- DEFM14A reportAug 10, 2026
- INST-CLUSTER reportAug 9, 2026
- DEFA14A, 8-K reportJul 16, 2026
- 144 reportJul 7, 2026
- PRESS-RELEASE reportJul 6, 2026
- 144 reportJul 3, 2026
- 144 reportJun 26, 2026
- 8-K reportJun 3, 2026
- PRESS-RELEASE reportMay 12, 2026
- PRESS-RELEASE reportApr 27, 2026
- 144 reportApr 20, 2026
- PRESS-RELEASE reportApr 8, 2026
- PRESS-RELEASE reportMar 24, 2026
- PRESS-RELEASE reportMar 17, 2026
- PRESS-RELEASE reportMar 10, 2026
- PRESS-RELEASE reportMar 6, 2026